-transparent.png){kind=logo}
Polyuria and polydipsia developed in two cases during amphotericin B therapy for deep mycoses. Neither patient could concentrate his urine in response to water deprivation or exogenous vasopressin. Other causes of vasopressin-resistant nephrogenic diabetes insipidus were not present. Three months after amphotericin B therapy had been discontinued, concentrating ability improved toward normal. A third patient was further observed and demonstrated normal diluting capacity but impaired free-water reabsorption, suggesting a distal tubular defect consistent with nephrogenic diabetes insipidus. Four months after discontinuing therapy, renal concentrating ability was normal. Amphotericin B can induce a reversible form of nephrogenic diabetes insipidus.
G L Barbour, and
K D Straub, and
B L O'Neal, and
J W Leatherman
May 2005,
Internal medicine (Tokyo, Japan),
G L Barbour, and
K D Straub, and
B L O'Neal, and
J W Leatherman
February 1960,
A.M.A. journal of diseases of children,
G L Barbour, and
K D Straub, and
B L O'Neal, and
J W Leatherman
January 2003,
The Annals of pharmacotherapy,
G L Barbour, and
K D Straub, and
B L O'Neal, and
J W Leatherman
November 1985,
Pediatriia,
G L Barbour, and
K D Straub, and
B L O'Neal, and
J W Leatherman
July 2001,
Pediatric nephrology (Berlin, Germany),
G L Barbour, and
K D Straub, and
B L O'Neal, and
J W Leatherman
October 1994,
The Clinical investigator,
G L Barbour, and
K D Straub, and
B L O'Neal, and
J W Leatherman
May 2005,
Internal medicine (Tokyo, Japan),
G L Barbour, and
K D Straub, and
B L O'Neal, and
J W Leatherman
March 1999,
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
G L Barbour, and
K D Straub, and
B L O'Neal, and
J W Leatherman
May 2009,
Pharmacotherapy,
G L Barbour, and
K D Straub, and
B L O'Neal, and
J W Leatherman
January 1994,
Bone marrow transplantation,
